Hutch News
Results per Page:
Un PLAN para personas hispanas y latinas con cáncer avanzado
Del Grupo Shen, División de Investigación Clínica
A PLAN for Hispanic and Latino patients with advanced cancer
From the Shen Group, Clinical Research Division
Weighing the benefits of hematopoietic stem cell transplantation for older and medically infirm patients with acute myeloid leukemia
From the Sorror Group, Clinical Research Division
The How To of faculty negotiations
From the Termini lab, Fred Hutch Clinical Research Division, and the Kong and Vasquez labs, University of Washington
Pediatric cancer disparities in Washington State
From the Chow Group, Clinical Research Division
Proliferation, proliferation, proliferation! Driver of HIV reservoir
From the Schiffer Group, Clinical Research Division
Decoding the function of clonally expanded T cells in kidney cancer
From the Warren Lab, Clinical Research Division
Depleting exhausted T cells enables memory T cells to be activated and fight blood cancer
From the Hill Lab, Clinical Research Division
Models of pediatric acute megakaryoblastic leukemia lead to new potential therapies
From the Meshinchi Lab, Clinical Research Division
Biomarker discovery for the early detection of esophageal adenocarcinoma and high-grade dysplasia
From the Grady Lab, Clinical Research Division
A liquid asset: Lung cancer tumor profiling from bronchoalveolar lavage fluid
From Dr. Viswam Nair, Clinical Research Division
Interactions between oncologists and patients – The lung cancer experience
From Dr. Casey Walsh, Fred Hutch Clinical Research Division, Dr. Morhaf Al Achkar, University of Washington, and colleagues
The impact of COVID-19 on pediatric hematopoietic stem cell transplant recipients
From Dr. Neel Bhatt, Clinical Research Division, and the Center for International Blood and Marrow Transplant Research
Navigating a new faculty position and the COVID-19 pandemic
From the Termini Lab, Clinical Research Division
Outcome predictions for patients with graft-versus-host disease
From the Hematopoietic Cell Transplantation Program, Clinical Research Division
The long-term impact of neurocognitive impairment after transplant
From the Chow Group, Clinical Research Division
No immature cells allowed – removing naïve T-cells in hematopoietic stem cell transplants
From the Bleakley Lab, Clinical Research Division
Breaking down barriers: Language and survival outcomes after transplant
From the Lee Lab, Clinical Research Division
Overcoming exhaustion: Engineered T-cells and pancreas cancer
From the Greenberg Lab, Clinical Research Division, Fred Hutch and the Stromnes Lab, University of Minnesota
Subverting the immunoproteasome in acute myeloid leukemia
From the Chapuis and Greenberg Labs, Clinical Research Division